[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Point of Care Testing for Infectious Disease Market 2024 by Company, Regions, Type and Application, Forecast to 2030

June 2024 | 109 pages | ID: G5A05694FDFAEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Point of Care Testing for Infectious Disease market size was valued at USD 10580 million in 2023 and is forecast to a readjusted size of USD 20050 million by 2030 with a CAGR of 9.6% during review period.

The Global Info Research report includes an overview of the development of the Point of Care Testing for Infectious Disease industry chain, the market status of Hospital (Immunological Test, Pathogen Nucleic Acid Test), Clinics (Immunological Test, Pathogen Nucleic Acid Test), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Point of Care Testing for Infectious Disease.

Regionally, the report analyzes the Point of Care Testing for Infectious Disease markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Point of Care Testing for Infectious Disease market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Point of Care Testing for Infectious Disease market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Point of Care Testing for Infectious Disease industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immunological Test, Pathogen Nucleic Acid Test).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Point of Care Testing for Infectious Disease market.

Regional Analysis: The report involves examining the Point of Care Testing for Infectious Disease market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Point of Care Testing for Infectious Disease market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Point of Care Testing for Infectious Disease:

Company Analysis: Report covers individual Point of Care Testing for Infectious Disease players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Point of Care Testing for Infectious Disease This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinics).

Technology Analysis: Report covers specific technologies relevant to Point of Care Testing for Infectious Disease. It assesses the current state, advancements, and potential future developments in Point of Care Testing for Infectious Disease areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Point of Care Testing for Infectious Disease market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Point of Care Testing for Infectious Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
  • Immunological Test
  • Pathogen Nucleic Acid Test
Market segment by Application
  • Hospital
  • Clinics
  • Others
Market segment by players, this report covers
  • Roche
  • Abbott
  • LifeScan
  • Siemens Healthineers
  • Danaher
  • Ascensia
  • BioMerieux
  • ARKRAY
  • Sinocare
  • Wondfo
  • Yuwell
  • Runbio
  • KHB
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Point of Care Testing for Infectious Disease product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Point of Care Testing for Infectious Disease, with revenue, gross margin and global market share of Point of Care Testing for Infectious Disease from 2019 to 2024.

Chapter 3, the Point of Care Testing for Infectious Disease competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Point of Care Testing for Infectious Disease market forecast, by regions, type and application, with consumption value, from 2025 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Point of Care Testing for Infectious Disease.

Chapter 13, to describe Point of Care Testing for Infectious Disease research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Point of Care Testing for Infectious Disease
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Point of Care Testing for Infectious Disease by Type
  1.3.1 Overview: Global Point of Care Testing for Infectious Disease Market Size by Type: 2019 Versus 2023 Versus 2030
  1.3.2 Global Point of Care Testing for Infectious Disease Consumption Value Market Share by Type in 2023
  1.3.3 Immunological Test
  1.3.4 Pathogen Nucleic Acid Test
1.4 Global Point of Care Testing for Infectious Disease Market by Application
  1.4.1 Overview: Global Point of Care Testing for Infectious Disease Market Size by Application: 2019 Versus 2023 Versus 2030
  1.4.2 Hospital
  1.4.3 Clinics
  1.4.4 Others
1.5 Global Point of Care Testing for Infectious Disease Market Size & Forecast
1.6 Global Point of Care Testing for Infectious Disease Market Size and Forecast by Region
  1.6.1 Global Point of Care Testing for Infectious Disease Market Size by Region: 2019 VS 2023 VS 2030
  1.6.2 Global Point of Care Testing for Infectious Disease Market Size by Region, (2019-2030)
  1.6.3 North America Point of Care Testing for Infectious Disease Market Size and Prospect (2019-2030)
  1.6.4 Europe Point of Care Testing for Infectious Disease Market Size and Prospect (2019-2030)
  1.6.5 Asia-Pacific Point of Care Testing for Infectious Disease Market Size and Prospect (2019-2030)
  1.6.6 South America Point of Care Testing for Infectious Disease Market Size and Prospect (2019-2030)
  1.6.7 Middle East and Africa Point of Care Testing for Infectious Disease Market Size and Prospect (2019-2030)

2 COMPANY PROFILES

2.1 Roche
  2.1.1 Roche Details
  2.1.2 Roche Major Business
  2.1.3 Roche Point of Care Testing for Infectious Disease Product and Solutions
  2.1.4 Roche Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  2.1.5 Roche Recent Developments and Future Plans
2.2 Abbott
  2.2.1 Abbott Details
  2.2.2 Abbott Major Business
  2.2.3 Abbott Point of Care Testing for Infectious Disease Product and Solutions
  2.2.4 Abbott Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  2.2.5 Abbott Recent Developments and Future Plans
2.3 LifeScan
  2.3.1 LifeScan Details
  2.3.2 LifeScan Major Business
  2.3.3 LifeScan Point of Care Testing for Infectious Disease Product and Solutions
  2.3.4 LifeScan Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  2.3.5 LifeScan Recent Developments and Future Plans
2.4 Siemens Healthineers
  2.4.1 Siemens Healthineers Details
  2.4.2 Siemens Healthineers Major Business
  2.4.3 Siemens Healthineers Point of Care Testing for Infectious Disease Product and Solutions
  2.4.4 Siemens Healthineers Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  2.4.5 Siemens Healthineers Recent Developments and Future Plans
2.5 Danaher
  2.5.1 Danaher Details
  2.5.2 Danaher Major Business
  2.5.3 Danaher Point of Care Testing for Infectious Disease Product and Solutions
  2.5.4 Danaher Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  2.5.5 Danaher Recent Developments and Future Plans
2.6 Ascensia
  2.6.1 Ascensia Details
  2.6.2 Ascensia Major Business
  2.6.3 Ascensia Point of Care Testing for Infectious Disease Product and Solutions
  2.6.4 Ascensia Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  2.6.5 Ascensia Recent Developments and Future Plans
2.7 BioMerieux
  2.7.1 BioMerieux Details
  2.7.2 BioMerieux Major Business
  2.7.3 BioMerieux Point of Care Testing for Infectious Disease Product and Solutions
  2.7.4 BioMerieux Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  2.7.5 BioMerieux Recent Developments and Future Plans
2.8 ARKRAY
  2.8.1 ARKRAY Details
  2.8.2 ARKRAY Major Business
  2.8.3 ARKRAY Point of Care Testing for Infectious Disease Product and Solutions
  2.8.4 ARKRAY Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  2.8.5 ARKRAY Recent Developments and Future Plans
2.9 Sinocare
  2.9.1 Sinocare Details
  2.9.2 Sinocare Major Business
  2.9.3 Sinocare Point of Care Testing for Infectious Disease Product and Solutions
  2.9.4 Sinocare Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  2.9.5 Sinocare Recent Developments and Future Plans
2.10 Wondfo
  2.10.1 Wondfo Details
  2.10.2 Wondfo Major Business
  2.10.3 Wondfo Point of Care Testing for Infectious Disease Product and Solutions
  2.10.4 Wondfo Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  2.10.5 Wondfo Recent Developments and Future Plans
2.11 Yuwell
  2.11.1 Yuwell Details
  2.11.2 Yuwell Major Business
  2.11.3 Yuwell Point of Care Testing for Infectious Disease Product and Solutions
  2.11.4 Yuwell Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  2.11.5 Yuwell Recent Developments and Future Plans
2.12 Runbio
  2.12.1 Runbio Details
  2.12.2 Runbio Major Business
  2.12.3 Runbio Point of Care Testing for Infectious Disease Product and Solutions
  2.12.4 Runbio Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  2.12.5 Runbio Recent Developments and Future Plans
2.13 KHB
  2.13.1 KHB Details
  2.13.2 KHB Major Business
  2.13.3 KHB Point of Care Testing for Infectious Disease Product and Solutions
  2.13.4 KHB Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
  2.13.5 KHB Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Point of Care Testing for Infectious Disease Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
  3.2.1 Market Share of Point of Care Testing for Infectious Disease by Company Revenue
  3.2.2 Top 3 Point of Care Testing for Infectious Disease Players Market Share in 2023
  3.2.3 Top 6 Point of Care Testing for Infectious Disease Players Market Share in 2023
3.3 Point of Care Testing for Infectious Disease Market: Overall Company Footprint Analysis
  3.3.1 Point of Care Testing for Infectious Disease Market: Region Footprint
  3.3.2 Point of Care Testing for Infectious Disease Market: Company Product Type Footprint
  3.3.3 Point of Care Testing for Infectious Disease Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Point of Care Testing for Infectious Disease Consumption Value and Market Share by Type (2019-2024)
4.2 Global Point of Care Testing for Infectious Disease Market Forecast by Type (2025-2030)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Point of Care Testing for Infectious Disease Consumption Value Market Share by Application (2019-2024)
5.2 Global Point of Care Testing for Infectious Disease Market Forecast by Application (2025-2030)

6 NORTH AMERICA

6.1 North America Point of Care Testing for Infectious Disease Consumption Value by Type (2019-2030)
6.2 North America Point of Care Testing for Infectious Disease Consumption Value by Application (2019-2030)
6.3 North America Point of Care Testing for Infectious Disease Market Size by Country
  6.3.1 North America Point of Care Testing for Infectious Disease Consumption Value by Country (2019-2030)
  6.3.2 United States Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)
  6.3.3 Canada Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)
  6.3.4 Mexico Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)

7 EUROPE

7.1 Europe Point of Care Testing for Infectious Disease Consumption Value by Type (2019-2030)
7.2 Europe Point of Care Testing for Infectious Disease Consumption Value by Application (2019-2030)
7.3 Europe Point of Care Testing for Infectious Disease Market Size by Country
  7.3.1 Europe Point of Care Testing for Infectious Disease Consumption Value by Country (2019-2030)
  7.3.2 Germany Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)
  7.3.3 France Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)
  7.3.4 United Kingdom Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)
  7.3.5 Russia Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)
  7.3.6 Italy Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)

8 ASIA-PACIFIC

8.1 Asia-Pacific Point of Care Testing for Infectious Disease Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Point of Care Testing for Infectious Disease Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Region
  8.3.1 Asia-Pacific Point of Care Testing for Infectious Disease Consumption Value by Region (2019-2030)
  8.3.2 China Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)
  8.3.3 Japan Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)
  8.3.4 South Korea Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)
  8.3.5 India Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)
  8.3.6 Southeast Asia Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)
  8.3.7 Australia Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)

9 SOUTH AMERICA

9.1 South America Point of Care Testing for Infectious Disease Consumption Value by Type (2019-2030)
9.2 South America Point of Care Testing for Infectious Disease Consumption Value by Application (2019-2030)
9.3 South America Point of Care Testing for Infectious Disease Market Size by Country
  9.3.1 South America Point of Care Testing for Infectious Disease Consumption Value by Country (2019-2030)
  9.3.2 Brazil Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)
  9.3.3 Argentina Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Point of Care Testing for Infectious Disease Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Point of Care Testing for Infectious Disease Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Country
  10.3.1 Middle East & Africa Point of Care Testing for Infectious Disease Consumption Value by Country (2019-2030)
  10.3.2 Turkey Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)
  10.3.3 Saudi Arabia Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)
  10.3.4 UAE Point of Care Testing for Infectious Disease Market Size and Forecast (2019-2030)

11 MARKET DYNAMICS

11.1 Point of Care Testing for Infectious Disease Market Drivers
11.2 Point of Care Testing for Infectious Disease Market Restraints
11.3 Point of Care Testing for Infectious Disease Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Point of Care Testing for Infectious Disease Industry Chain
12.2 Point of Care Testing for Infectious Disease Upstream Analysis
12.3 Point of Care Testing for Infectious Disease Midstream Analysis
12.4 Point of Care Testing for Infectious Disease Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

LIST OF TABLES

Table 1. Global Point of Care Testing for Infectious Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Point of Care Testing for Infectious Disease Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Point of Care Testing for Infectious Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Point of Care Testing for Infectious Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Point of Care Testing for Infectious Disease Product and Solutions
Table 8. Roche Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Roche Recent Developments and Future Plans
Table 10. Abbott Company Information, Head Office, and Major Competitors
Table 11. Abbott Major Business
Table 12. Abbott Point of Care Testing for Infectious Disease Product and Solutions
Table 13. Abbott Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Abbott Recent Developments and Future Plans
Table 15. LifeScan Company Information, Head Office, and Major Competitors
Table 16. LifeScan Major Business
Table 17. LifeScan Point of Care Testing for Infectious Disease Product and Solutions
Table 18. LifeScan Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. LifeScan Recent Developments and Future Plans
Table 20. Siemens Healthineers Company Information, Head Office, and Major Competitors
Table 21. Siemens Healthineers Major Business
Table 22. Siemens Healthineers Point of Care Testing for Infectious Disease Product and Solutions
Table 23. Siemens Healthineers Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Siemens Healthineers Recent Developments and Future Plans
Table 25. Danaher Company Information, Head Office, and Major Competitors
Table 26. Danaher Major Business
Table 27. Danaher Point of Care Testing for Infectious Disease Product and Solutions
Table 28. Danaher Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Danaher Recent Developments and Future Plans
Table 30. Ascensia Company Information, Head Office, and Major Competitors
Table 31. Ascensia Major Business
Table 32. Ascensia Point of Care Testing for Infectious Disease Product and Solutions
Table 33. Ascensia Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Ascensia Recent Developments and Future Plans
Table 35. BioMerieux Company Information, Head Office, and Major Competitors
Table 36. BioMerieux Major Business
Table 37. BioMerieux Point of Care Testing for Infectious Disease Product and Solutions
Table 38. BioMerieux Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. BioMerieux Recent Developments and Future Plans
Table 40. ARKRAY Company Information, Head Office, and Major Competitors
Table 41. ARKRAY Major Business
Table 42. ARKRAY Point of Care Testing for Infectious Disease Product and Solutions
Table 43. ARKRAY Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. ARKRAY Recent Developments and Future Plans
Table 45. Sinocare Company Information, Head Office, and Major Competitors
Table 46. Sinocare Major Business
Table 47. Sinocare Point of Care Testing for Infectious Disease Product and Solutions
Table 48. Sinocare Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Sinocare Recent Developments and Future Plans
Table 50. Wondfo Company Information, Head Office, and Major Competitors
Table 51. Wondfo Major Business
Table 52. Wondfo Point of Care Testing for Infectious Disease Product and Solutions
Table 53. Wondfo Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Wondfo Recent Developments and Future Plans
Table 55. Yuwell Company Information, Head Office, and Major Competitors
Table 56. Yuwell Major Business
Table 57. Yuwell Point of Care Testing for Infectious Disease Product and Solutions
Table 58. Yuwell Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Yuwell Recent Developments and Future Plans
Table 60. Runbio Company Information, Head Office, and Major Competitors
Table 61. Runbio Major Business
Table 62. Runbio Point of Care Testing for Infectious Disease Product and Solutions
Table 63. Runbio Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Runbio Recent Developments and Future Plans
Table 65. KHB Company Information, Head Office, and Major Competitors
Table 66. KHB Major Business
Table 67. KHB Point of Care Testing for Infectious Disease Product and Solutions
Table 68. KHB Point of Care Testing for Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. KHB Recent Developments and Future Plans
Table 70. Global Point of Care Testing for Infectious Disease Revenue (USD Million) by Players (2019-2024)
Table 71. Global Point of Care Testing for Infectious Disease Revenue Share by Players (2019-2024)
Table 72. Breakdown of Point of Care Testing for Infectious Disease by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Point of Care Testing for Infectious Disease, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 74. Head Office of Key Point of Care Testing for Infectious Disease Players
Table 75. Point of Care Testing for Infectious Disease Market: Company Product Type Footprint
Table 76. Point of Care Testing for Infectious Disease Market: Company Product Application Footprint
Table 77. Point of Care Testing for Infectious Disease New Market Entrants and Barriers to Market Entry
Table 78. Point of Care Testing for Infectious Disease Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Point of Care Testing for Infectious Disease Consumption Value (USD Million) by Type (2019-2024)
Table 80. Global Point of Care Testing for Infectious Disease Consumption Value Share by Type (2019-2024)
Table 81. Global Point of Care Testing for Infectious Disease Consumption Value Forecast by Type (2025-2030)
Table 82. Global Point of Care Testing for Infectious Disease Consumption Value by Application (2019-2024)
Table 83. Global Point of Care Testing for Infectious Disease Consumption Value Forecast by Application (2025-2030)
Table 84. North America Point of Care Testing for Infectious Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 85. North America Point of Care Testing for Infectious Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 86. North America Point of Care Testing for Infectious Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 87. North America Point of Care Testing for Infectious Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 88. North America Point of Care Testing for Infectious Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 89. North America Point of Care Testing for Infectious Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 90. Europe Point of Care Testing for Infectious Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Europe Point of Care Testing for Infectious Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Europe Point of Care Testing for Infectious Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 93. Europe Point of Care Testing for Infectious Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 94. Europe Point of Care Testing for Infectious Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Point of Care Testing for Infectious Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Point of Care Testing for Infectious Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 97. Asia-Pacific Point of Care Testing for Infectious Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 98. Asia-Pacific Point of Care Testing for Infectious Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 99. Asia-Pacific Point of Care Testing for Infectious Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 100. Asia-Pacific Point of Care Testing for Infectious Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 101. Asia-Pacific Point of Care Testing for Infectious Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 102. South America Point of Care Testing for Infectious Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 103. South America Point of Care Testing for Infectious Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 104. South America Point of Care Testing for Infectious Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 105. South America Point of Care Testing for Infectious Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 106. South America Point of Care Testing for Infectious Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 107. South America Point of Care Testing for Infectious Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Middle East & Africa Point of Care Testing for Infectious Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 109. Middle East & Africa Point of Care Testing for Infectious Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 110. Middle East & Africa Point of Care Testing for Infectious Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 111. Middle East & Africa Point of Care Testing for Infectious Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 112. Middle East & Africa Point of Care Testing for Infectious Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 113. Middle East & Africa Point of Care Testing for Infectious Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 114. Point of Care Testing for Infectious Disease Raw Material
Table 115. Key Suppliers of Point of Care Testing for Infectious Disease Raw Materials

LIST OF FIGURES

Figure 1. Point of Care Testing for Infectious Disease Picture
Figure 2. Global Point of Care Testing for Infectious Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Point of Care Testing for Infectious Disease Consumption Value Market Share by Type in 2023
Figure 4. Immunological Test
Figure 5. Pathogen Nucleic Acid Test
Figure 6. Global Point of Care Testing for Infectious Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Point of Care Testing for Infectious Disease Consumption Value Market Share by Application in 2023
Figure 8. Hospital Picture
Figure 9. Clinics Picture
Figure 10. Others Picture
Figure 11. Global Point of Care Testing for Infectious Disease Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Point of Care Testing for Infectious Disease Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Point of Care Testing for Infectious Disease Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Point of Care Testing for Infectious Disease Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Point of Care Testing for Infectious Disease Consumption Value Market Share by Region in 2023
Figure 16. North America Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Point of Care Testing for Infectious Disease Revenue Share by Players in 2023
Figure 22. Point of Care Testing for Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Point of Care Testing for Infectious Disease Market Share in 2023
Figure 24. Global Top 6 Players Point of Care Testing for Infectious Disease Market Share in 2023
Figure 25. Global Point of Care Testing for Infectious Disease Consumption Value Share by Type (2019-2024)
Figure 26. Global Point of Care Testing for Infectious Disease Market Share Forecast by Type (2025-2030)
Figure 27. Global Point of Care Testing for Infectious Disease Consumption Value Share by Application (2019-2024)
Figure 28. Global Point of Care Testing for Infectious Disease Market Share Forecast by Application (2025-2030)
Figure 29. North America Point of Care Testing for Infectious Disease Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Point of Care Testing for Infectious Disease Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Point of Care Testing for Infectious Disease Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Point of Care Testing for Infectious Disease Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Point of Care Testing for Infectious Disease Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Point of Care Testing for Infectious Disease Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 39. France Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Point of Care Testing for Infectious Disease Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Point of Care Testing for Infectious Disease Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Point of Care Testing for Infectious Disease Consumption Value Market Share by Region (2019-2030)
Figure 46. China Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 49. India Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Point of Care Testing for Infectious Disease Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Point of Care Testing for Infectious Disease Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Point of Care Testing for Infectious Disease Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Point of Care Testing for Infectious Disease Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Point of Care Testing for Infectious Disease Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Point of Care Testing for Infectious Disease Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Point of Care Testing for Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 63. Point of Care Testing for Infectious Disease Market Drivers
Figure 64. Point of Care Testing for Infectious Disease Market Restraints
Figure 65. Point of Care Testing for Infectious Disease Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Point of Care Testing for Infectious Disease in 2023
Figure 68. Manufacturing Process Analysis of Point of Care Testing for Infectious Disease
Figure 69. Point of Care Testing for Infectious Disease Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source


More Publications